Company Filing History:
Years Active: 2009
Title: Michael Loreto: Innovator in Cancer Research
Introduction
Michael Loreto is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of cancer research through his innovative work on the MARS gene. His research focuses on the implications of this gene in human cancers and its potential applications in diagnosis and therapy.
Latest Patents
Michael Loreto holds a patent for an invention titled "Adapter gene." This invention relates to the identification and cloning of a novel gene, MARS (Modulator of Antigen Receptor Signaling), which is considered a putative tumor suppressor gene. The patent outlines the relationship of the MARS gene to human cancers and its use in the diagnosis and prognosis of these conditions. Additionally, it discusses therapeutic approaches for cancers that have mutations in the MARS gene or lack it entirely, including gene therapy, protein replacement therapy, and protein mimetics. The invention also encompasses the screening of drugs for cancer therapy.
Career Highlights
Michael Loreto is affiliated with The Hospital for Sick Children, where he conducts his research. His work has garnered attention for its potential to improve cancer treatment and patient outcomes. With a focus on innovative solutions, he continues to explore the therapeutic possibilities of the MARS gene.
Collaborations
Michael collaborates with various professionals in the field, including his coworker Jane McGlade. Their combined expertise contributes to advancing research in cancer therapies and diagnostics.
Conclusion
Michael Loreto's contributions to cancer research through his patent on the MARS gene highlight the importance of innovation in medical science. His work has the potential to significantly impact the diagnosis and treatment of human cancers.